Polydex Pharmaceuticals Ltd. (OTCMKTS:POLXF – Get Free Report) crossed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $1.99 and traded as low as $1.9860. Polydex Pharmaceuticals shares last traded at $1.9860, with a volume of 2,000 shares.
Polydex Pharmaceuticals Trading Up 0.3%
The business has a 50-day simple moving average of $1.99 and a 200-day simple moving average of $1.99.
About Polydex Pharmaceuticals
Polydex Pharmaceuticals Ltd. is a development stage company, which engages in manufacturing of bulk pharmaceutical intermediates for the worldwide veterinary pharmaceutical industry, and the development, manufacturing, and marketing of biotechnology-based products for the human pharmaceutical market. The firm focuses on Dextran and derivative products, including Iron Dextran and Dextran Sulphate and other specialty chemicals. The company was founded by Thomas C. Usher on June 14, 1979 and is headquartered in Toronto, Canada.
Further Reading
- Five stocks we like better than Polydex Pharmaceuticals
- AirJoule’s Kubota Deal Is a Major Validation—But the Hard Part Comes Next
- Dividend Stocks May Be the Quiet Rotation Trade Investors Are Missing Now
- Refiner Stocks Are Near Record Highs—Can Iran-Driven Margins Keep Them There?
- Verizon May Be an AI Infrastructure Stock Hiding in Plain Sight
Receive News & Ratings for Polydex Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Polydex Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
